Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2654${count})

  • ASAP CRN Discovery Fellowship 2025, 2026
    How the Spatiotemporal Dynamics of Dopamine Transmission Shift in Parkinson’s Disease to Support Motor Function
    ASAP logo

    Study Rationale:                         

    Loss of dopamine in the brain is the main cause of Parkinson’s disease motor symptoms. Previous research shows that the brain can lose many of the cells that...

  • ASAP CRN Discovery Fellowship 2025, 2026
    Dynamic Regulatory Role of Transposable Elements Through Human Ageing and Parkinson’s Disease
    ASAP logo

    Study Rationale:                         

    Many people assume that most of our DNA is made up of genes, but in fact, genes account for only about 2% of the human genome. More than half is made up of...

  • ASAP CRN Discovery Fellowship 2025, 2026
    Recapitulating Subtype-Specific Cell-Autonomous Human Dopaminergic Vulnerability in Parkinson’s Disease
    ASAP logo

    Study Rationale:                         

    In Parkinson’s disease (PD), certain brain cells that make dopamine, called A9 neurons, slowly die. These cells are very active and have long, branching...

  • ASAP CRN Discovery Fellowship 2025, 2026
    Exploring How Mutations in the LRRK2 Gene Change mRNA and Protein Selection and How This Can Be Used for Diagnosis and Treatment of Parkinson’s Disease
    ASAP logo

    Study Rationale:

    Mutations in the LRRK2 gene are the most common inherited cause of Parkinson’s disease. These changes affect how cells read and process genetic messages, producing different versions...

  • ASAP CRN 2025 RFA Scientific Track, 2026
    RNA Mechanisms of Resilience and Vulnerability in Aging and Parkinson’s Disease
    ASAP logo

    Study Rationale:        

    Parkinson’s disease (PD) is the fastest-growing neurodegenerative disorder, yet we still don’t fully understand why brain cells become vulnerable and die. Recent work suggests...

  • ASAP CRN 2025 RFA Scientific Track, 2026
    Environmental & Genetic Determinants of Parkinson’s Disease Progression
    ASAP logo

    Study Rationale:                         

    Several genetic and environmental factors determine the risk of developing Parkinson’s disease (PD) and how fast the disease progresses.  We have identified 2...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.